Categories
GeekWire

New clues in the search for the roots of consciousness

Seven years after they started, neuroscientists have published the results of a landmark study that was designed to determine which theory of human consciousness came closest to the mark — and those results are decidedly mixed.

The bad news is that neither of the leading theories held a clear advantage in explaining how consciousness arises. The good news is that researchers picked up new clues about where to look.

One of the leaders of the effort — Christof Koch, a meritorious investigator at the Seattle-based Allen Institute — said he was heartened by the state of the debate.

“Adversarial collaboration fits within the Allen Institute’s mission of team science, open science and big science, in service of one of the biggest, and most long-standing, intellectual challenges of humanity: the Mind-Body Problem,” Koch said in a news release. “Unraveling this mystery is the passion of my entire life.”

Categories
GeekWire

Elon Musk’s views on artificial vision get a reality check

If Elon Musk’s Neuralink brain-implant venture succeeds in its effort to create next-generation brain implants for artificial vision, the devices could bring about a breakthrough for those with impaired sight — but probably wouldn’t match Musk’s claim that they could provide “better than normal vision,” University of Washington researchers report.

In a study published today by the open-access science journal Scientific Reports, UW psychologists Ione Fine and Geoffrey Boynton point out that the brain’s vision system relies on complex interactions between neurons that don’t directly translate into a pixel-by-pixel picture.

“Engineers often think of electrodes as producing pixels, but that is simply not how biology works,” Fine said in a news release. “We hope that our simulations based on a simple model of the visual system can give insight into how these implants are going to perform. These simulations are very different from the intuition an engineer might have if they are thinking in terms of a pixels on a computer screen.”

Categories
GeekWire

Scientists harness generative AI for cancer diagnosis

Researchers at Microsoft, Providence Health System and the University of Washington say they’ve developed a new artificial intelligence model for diagnosing cancer, based on an analysis of more than a billion images of tissue samples from more than 30,000 patients.

The open-access model, known as Prov-GigaPath, is described in research published today by the journal Nature and is already being used in clinical applications.

“The rich data in pathology slides can, through AI tools like Prov-GigaPath, uncover novel relationships and insights that go beyond what the human eye can discern,” study co-author Carlo Bifulco, chief medical officer of Providence Genomics, said in a news release. “Recognizing the potential of this model to significantly advance cancer research and diagnostics, we felt strongly about making it widely available to benefit patients globally. It’s an honor to be part of this groundbreaking work.”

The effort to develop Prov-GigaPath used AI tools to identify patterns in 1.3 billion pathology image tiles obtained from 171,189 digital whole-slides provided by Providence. The researchers say this was the largest pre-training effort to date with whole-slide modeling — drawing upon a database five to 10 times larger than datasets such as the The Cancer Genome Atlas.

Categories
GeekWire

Scientists unveil complete cell atlas for mouse brain

Neuroscientists have unveiled their most comprehensive and detailed map of cell types across the entire mouse brain, delivering the latest results of a six-year-long scientific effort in which Seattle’s Allen Institute has played a leading role.

Nine studies published today in the journal Nature document the identification of 5,322 different types of brain cells, and trace the similarities and differences found in a variety of mammalian species — including humans.

The work expands upon previous studies from the BRAIN Initiative Cell Census Network, including earlier surveys of cells in various regions of the mouse brain, as well as cross-species comparisons of cell functions. Researchers from the Allen Institute joined forces with colleagues from the Broad Institute, Harvard, the Salk Institute for Biological Studies, the University of California at San Diego, UC-Berkeley and other institutions to add to their “parts list” for the brain.

“Now we have the cell-type atlas of all the cells in the brain,” Hongkui Zeng, executive vice president and director of the Allen Institute for Brain Science, said in an explanatory video. “This is really a landmark achievement. … It marks the completion of a kind of work that strives for completeness. But it also marks the beginning of the next phase of the journey. It just opens up the door for the next generation of investigations.”

Zeng, who is the senior author of one of the papers in Nature and a co-author of five others, said the next step will be to figure out exactly what all those different cell types do, how their functions are affected by disease, and whether there might be yet-to-be-discovered ways to restore those proper functions.

“It’s not just about a catalog, a list of cell types and where they are — reference information which by itself is already important — but we begin to see how a brain is organized,” Zeng said.

Categories
GeekWire

Scientists team up to turn cells into tiny recording devices

The Allen Institute, the Chan Zuckerberg Initiative and the University of Washington have launched a collaboration called the Seattle Hub for Synthetic Biology, with the goal of using genetically modified cells to capture a DNA-based record showing how they change over time.

If the project works out as hoped, it could lead to a deeper understanding of the mechanisms behind cellular processes — including, for example, how tumors grow — and point to new methods for fighting disease and promoting healthy cell growth.

Over the next five years, the Seattle Hub for Synthetic Biology will receive $35 million from the Allen Institute, and another $35 million from the Chan Zuckerberg Initiative, founded by Meta CEO Mark Zuckerberg and his wife, Priscilla Chan.

Categories
GeekWire

Contest offers $101M for ways to boost healthy lifespan

Some of the biggest names in longevity research — and at least one Seattle biotech startup — say they’ll enter a $101 million, seven-year competition to turn back the clock on the effects of aging by at least 10 years.

XPRIZE Healthspan was unveiled today at a conference in Riyadh, Saudi Arabia. It’s the richest incentive-based technology competition ever created by the XPRIZE foundation, beating out a $100 million XPRIZE Carbon Removal contest that’s being funded by Elon Musk, the world’s richest (and most controversial) billionaire.

The top prize in the Healthspan contest will go to the team that does the best job of creating a therapy that can be administered in a year or less, leading to the restoration of at least 10 years’ worth of muscular function, cognition and immune function in people aged 65 to 80.

Peter Diamandis, the founder and executive chairman of XPRIZE, said the concept started out as a longevity prize, but the program’s planners “realized that the idea of waiting 20 years to see if someone won the prize was probably impractical.”

“We shifted from longevity to really looking at age reversal first, and then functional restoration second,” Diamandis explained. “You see, it doesn’t really matter what your epigenetic age is. Do you actually feel younger? Do you have the muscle, immune and cognition that you had 10 or 20 years ago? Because at the end of the game, that’s what really matters.”

Categories
GeekWire

Allen Frontiers Group awards $10M for neuroimmunology

The Paul G. Allen Frontiers Group, a division of the Seattle-based Allen Institute, is launching a research center in New York to focus on interactions between the nervous system and the immune system.

The Allen Discovery Center for Neuroimmune Interactions, headquartered at the Icahn School of Medicine at Mount Sinai, will receive $10 million over the course of four years from the Paul G. Allen Family Foundation, with a total potential for $20 million over eight years.

The award is the result of an open call for research proposals exploring fundamental questions at the intersection of neuroscience and immunology. It’s the latest open-science initiative celebrating the legacy of Microsoft co-founder Paul Allen, who died five years ago at the age of 65 from complications of non-Hodgkin’s lymphoma.

Categories
GeekWire

Brain-cell atlases point to paths for future research

In a tour de force for neuroscience, teams of researchers have published a voluminous set of brain-cell atlases for humans and other primates.

The atlases are detailed in 21 research papers appearing in ScienceScience Advances and Science Translational Medicine — and could point scientists toward new strategies for addressing mental conditions ranging from Alzheimer’s disease and schizophrenia to epilepsy and ADHD.

“We need to understand the specifics of the human brain if we hope to understand human diseases,” Ed Lein, a senior investigator at Seattle’s Allen Institute, said in comments provided via video.

“Most of disease research tries to create a replicate or a model of a human disease in a species that doesn’t get that disease,” Lein explained. “But if we want to understand why we get it, and what the consequences are, and how one should treat it, we need to have a deep understanding of the human brain itself.”

The studies in the package released today are part of the National Institutes of Health’s BRAIN Initiative Cell Census Network, or BICCN, a program that was launched in 2017. The Allen Institute for Brain Science has played a major role in sharing data produced by the program.

One study analyzed more than a million cells taken from 42 regions of the brain. Another study drew high-quality samples from more than 100 brain regions. Yet another study focused on samples from prenatal brain tissue. The collective efforts of the research teams characterized more than 3,000 human brain cell types.

The researchers didn’t just examine the brain cells themselves. They also ran them through DNA analysis to learn which genes appeared to be linked to the cells’ functions and dysfunctions.

Categories
GeekWire

Experiment blazes a trail for growing stem cells in space

Space: The final frontier … for stem cells? Seattle’s Allen Institute for Cell Science says cells from its collection are going into space for the first time on a private mission to the International Space Station.

The Allen Cell Collection’s assortment of human induced pluripotent stem cells, or IPSCs, will be the focus for one of more than 20 experiments being sent into orbit on a flight organized by Texas-based Axiom Space.

Former NASA astronaut Peggy Whitson will command the Ax-2 mission — Axiom’s second trip to the space station — and her crewmates will include Tennessee business executive John Shoffner as well as Saudi astronauts Ali Alqarni and Rayyanah Barnawi.

SpaceX’s Falcon 9 rocket will loft the crew into orbit in a SpaceX Crew Dragon capsule for what’s expected to be a weeklong stay on the station. Liftoff is set for May 21 at 5:37 p.m. ET (2:37 p.m. PT) at NASA’s Kennedy Space Center in Florida. The fare for each rider on last year’s Ax-1 mission was around $55 million, and although the ticket price for Ax-2 hasn’t been announced, it’s probably in a similar range.

The stem-cell study is part of a series of NASA-funded experiments led by researchers at Cedars-Sinai Medical Center in Los Angeles. This experiment is expected to break new ground when it comes to growing IPSCs in space and modifying the cells’ DNA for therapeutic purposes.

Categories
GeekWire

‘Kidney on a chip’ gets another ride to space

SpaceX launched a Dragon cargo capsule to the International Space Station today with more than 7,300 pounds of supplies and science, including an experiment from the University of Washington that takes advantage of zero gravity to study how our kidneys work.

The resupply mission began at 1:29 p.m. ET (10:29 a.m. PT) with liftoff for SpaceX’s Falcon 9 rocket from NASA’s Kennedy Space Center in Florida. Minutes after launch, the Falcon’s first-stage booster flew itself back to an at-sea touchdown in the Atlantic Ocean, while the Dragon continued its rise to orbit.

Rendezvous with the space station took place on June 5.

SpaceX’s 22nd cargo resupply mission is carrying a wide range of science experiments. One will use glow-in-the dark bobtail squid to study the impact of spaceflight on interactions between microbes and their hosts. Another will study how tardigrades are able to weather the rigors of space. And then there’s UW’s “kidney on a chip.”